Skip to main content
Year archive

Galapagos NV — 2023 filings

All 121 regulatory filings released by Galapagos NV (GLPG) in 2023, sourced directly from the official regulator.

121 Filings
2023 Period
2023 filings (121)
Filing Released Lang
6-K Filing
Foreign Filer Report
2023-12-21 English
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301
Regulatory Filings
2023-12-20 English
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301
Earnings Release Q4 2023
2023-12-20 English
6-K Filing
Foreign Filer Report
2023-12-12 English
6-K Filing
Foreign Filer Report
2023-12-12 English
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101
Earnings Release Q4 2023
2023-12-11 English
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101
Investor Presentation
2023-12-11 English
Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023
Regulatory Filings
2023-12-08 English
Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023
Investor Presentation
2023-12-08 Dutch
S-8 Filing
Registration Form
2023-12-04 English
Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023
Earnings Release 9M 2023
2023-11-03 Dutch
Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023
Earnings Release 9M 2023
2023-11-03 Dutch
6-K Filing
Foreign Filer Report
2023-11-03 English
Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023.pdf
Earnings Release 9M 2023
2023-11-02 English
Galapagos rapporteert derde kwartaal 2023 resultaten en deelt nieuwe bemoedigende data van CAR-T studies die op ASH 2023 gepresenteerd worden .pdf
Earnings Release 9M 2023
2023-11-02 Dutch
6-K Filing
Foreign Filer Report
2023-11-02 English
Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma
M&A Activity
2023-10-31 Dutch
Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma
M&A Activity
2023-10-31 English
231030 GLPG Press Release Alfasigma_Final_ENG.pdf
M&A Activity
2023-10-30 English
231030 GLPG Press Release Alfasigma_Final_NL.pdf
M&A Activity
2023-10-30 Dutch
Galapagos appoints Simon Sturge to its Board of Directors
Board/Management Information
2023-09-20 English
Galapagos appoints Simon Sturge to its Board of Directors
Board/Management Information
2023-09-20 English
6-K Filing
Foreign Filer Report
2023-09-20 English
6-K Filing
Foreign Filer Report
2023-08-30 English
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus
Regulatory Filings
2023-08-29 English
Galapagos rapporteert financiële resultaten over het eerste halfjaar van 2023
Earnings Release H1 2023
2023-08-04 Dutch
6-K Filing
Foreign Filer Report
2023-08-04 English
Galapagos announces first half-year 2023 financial results.pdf
Interim / Quarterly Report H1 2023
2023-08-03 English
Galapagos rapporteert financiële resultaten over het eerste halfjaar van 2023.pdf
Earnings Release H1 2023
2023-08-03 Dutch
Half-year financial report 2023.pdf
Interim / Quarterly Report H1 2023
2023-08-03 English
Halfjaarverslag 2023.pdf
Interim / Quarterly Report H1 2023
2023-08-03 Dutch
Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
Board/Management Information
2023-06-16 Dutch
Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
Board/Management Information
2023-06-16 English
PR CFO COO Appointment_ENG_Final.pdf
Board/Management Information
2023-06-15 English
PR CFO COO Appointment_NL_Final.pdf
Board/Management Information
2023-06-15 Dutch
6-K Filing
Foreign Filer Report
2023-06-15 English
Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board
Board/Management Information
2023-06-13 Dutch
Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board
Board/Management Information
2023-06-13 English
6-K Filing
Foreign Filer Report
2023-06-13 English
6-K Filing
Foreign Filer Report
2023-06-12 English
SC 13G Filing
Major Shareholding Notification
2023-06-07 English
Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at the EHA 2023 congress
Regulatory Filings
2023-06-06 English
6-K Filing
Foreign Filer Report
2023-05-26 English
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with dermatomyositis
Regulatory Filings
2023-05-24 English
Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023
Regulatory Filings
2023-05-23 English
6-K Filing
Foreign Filer Report
2023-05-23 English
Subscription_Right_Plan_2023_BE_RMV_ROW_RvB_Report_7_180-7_191_D_Final.docx.pdf
Capital/Financing Update
2023-05-09 Dutch
Subscription Right Plan 2023 BE_RMV_ROW_RvB Report_7_180-7_191_D_Final.docx.pdf
Capital/Financing Update
2023-05-09 Dutch
GLPG - Uitgifte obl inschr EN beperk voork ENG 2023.pdf
Audit Report / Information FY 2023
2023-05-09 English
GLPG - Uitgifte obl inschr EN beperk voork 2023.pdf
Regulatory Filings
2023-05-09 Dutch
6-K Filing
Foreign Filer Report
2023-05-09 English
2023 AGM Minutes - ENG(573149.1).pdf
AGM Information
2023-05-08 English
2023 AGM minutes - NL(573148.1).pdf
AGM Information
2023-05-08 Dutch
Galapagos creates new subscription right plans
Share Issue/Capital Change
2023-05-08 Dutch
Galapagos creates new subscription right plans
Share Issue/Capital Change
2023-05-08 English
Galapagos announces first quarter 2023 financial results
Earnings Release Q1 2023
2023-05-05 Dutch
Galapagos announces first quarter 2023 financial results
Earnings Release Q1 2023
2023-05-05 English
6-K Filing
Foreign Filer Report
2023-05-05 English
Galapagos announces first quarter 2023 financial results .pdf
Earnings Release Q1 2023
2023-05-04 English
Galapagos rapporteert financiële resultaten voor het eerste kwartaal van 2023 .pdf
Earnings Release Q1 2023
2023-05-04 Dutch
Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial Officer
Board/Management Information
2023-05-03 English
Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial Officer
Board/Management Information
2023-05-03 Dutch
press-release-galapagos-announces-departure-of-bart-filius-c.pdf
Board/Management Information
2023-05-02 English
persbericht-galapagos-kondigt-vertrek-aan-van-bart-filius-ch.pdf
Board/Management Information
2023-05-02 Dutch
6-K Filing
Foreign Filer Report
2023-05-02 English
6-K Filing
Foreign Filer Report
2023-05-02 English
Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis
Regulatory Filings
2023-04-27 Dutch
Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis
Legal Proceedings Report
2023-04-27 English
Galapagos’ shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders’ meeting
AGM Information
2023-04-26 English
Galapagos’ shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders’ meeting
AGM Information
2023-04-26 Dutch
6-K Filing
Foreign Filer Report
2023-04-26 English
6-K Filing
Foreign Filer Report
2023-04-25 English
Galapagos and NovAliX enter into an integrated drug discovery collaboration
M&A Activity
2023-03-31 English
Galapagos and NovAliX enter into an integrated drug discovery collaboration
M&A Activity
2023-03-31 English
6-K Filing
Foreign Filer Report
2023-03-31 English
6-K Filing
Foreign Filer Report
2023-03-27 English
Galapagos publishes 2022 annual report and announces Annual Shareholders’ Meeting
Report Publication Announcement
2023-03-24 English
Galapagos publishes 2022 annual report and announces Annual Shareholders’ Meeting
Report Publication Announcement
2023-03-24 English
0271_001.pdf
AGM Information
2023-03-23 Dutch
Galapagos publishes 2022 annual report and announces Annual Shareholders’ Meeting.pdf
Report Publication Announcement
2023-03-23 English
Galapagos publiceert jaarverslag 2022 en kondigt Gewone Algemene Vergadering aan.pdf
Report Publication Announcement
2023-03-23 Dutch
Annual report 2022.pdf
Annual Report FY 2022
2023-03-23 English
Jaarverslag 2022.pdf
Annual Report FY 2022
2023-03-23 Dutch
699400FG6E2AD50YHF38-2022-12-31-nl (2).zip
Annual Report (ESEF) FY 2022
2023-03-23 Dutch
699400FG6E2AD50YHF38-2022-12-31-nl.xhtml
Annual Report FY 2022
2023-03-23 Dutch
20-F Filing
Annual Report FY 2022
2023-03-23 English
6-K Filing
Foreign Filer Report
2023-03-23 English
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2023-03-21 Dutch
Galapagos increases share capital through subscription right exercises.pdf
Share Issue/Capital Change
2023-03-20 English
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten.pdf
Share Issue/Capital Change
2023-03-20 Dutch
Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023
Report Publication Announcement
2023-02-28 Dutch
Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023
Earnings Release Q1 2023
2023-02-28 English
6-K Filing
Foreign Filer Report
2023-02-28 English
Galapagos announces full year 2022 results and outlook for 2023
Earnings Release FY 2022
2023-02-24 English
Galapagos announces full year 2022 results and outlook for 2023
Audit Report / Information FY 2022
2023-02-24 English
6-K Filing
Foreign Filer Report
2023-02-24 English
fy22_financial_tables_en.pdf
Audit Report / Information FY 2022
2023-02-23 English
fy22_financial_tables_nl.pdf
Interim / Quarterly Report FY 2022
2023-02-23 Dutch
Galapagos announces full year 2022 results and outlook for 2023.pdf
Earnings Release FY 2022
2023-02-23 English
Galapagos kondigt 2022 jaarresultaten en vooruitzichten 2023 aan.pdf
Earnings Release FY 2022
2023-02-23 Dutch
SC 13G/A Filing
Major Shareholding Notification
2023-02-14 English
Galapagos presented encouraging initial safety and efficacy data at 2023 EBMT-EHA for point-of-care manufactured CAR-T candidate, GLPG5201, in rrCLL
Earnings Release Q1 2023
2023-02-10 English
Galapagos presented encouraging initial safety and efficacy data at 2023 EBMT-EHA for point-of-care manufactured CAR-T candidate, GLPG5201, in rrCLL
Earnings Release Q1 2023
2023-02-10 Dutch
6-K Filing
Foreign Filer Report
2023-02-10 English
Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease
Earnings Release Q1 2023
2023-02-09 English
Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease
Earnings Release Q1 2023
2023-02-09 English
SC 13G Filing
Major Shareholding Notification
2023-02-09 English
230208_GLPG DIVERSITY press release ENG.pdf
Earnings Release Q1 2023
2023-02-08 English
230208_GLPG DIVERSITY press release NL.pdf
Earnings Release Q1 2023
2023-02-08 Dutch
6-K Filing
Foreign Filer Report
2023-02-08 English
6-K Filing
Foreign Filer Report
2023-01-19 English
Galapagos receives transparency notification from FMR LLC
Major Shareholding Notification
2023-01-13 English
Galapagos receives transparency notification from FMR LLC
Major Shareholding Notification
2023-01-13 English
Galapagos receives transparency notification from FMR LLC
Major Shareholding Notification
2023-01-11 English
Galapagos receives transparency notification from FMR LLC
Major Shareholding Notification
2023-01-11 English
GALAPAGOS GENOMICS NV TR-1BE-ENG FMR TD2023-01-05 - Final (Part I)_Redacted.pdf
Major Shareholding Notification
2023-01-10 English
Galapagos receives transparency notification from FMR LLC.pdf
Director's Dealing
2023-01-10 English
Galapagos ontvangt transparantieverklaring van FMR LLC.pdf
Major Shareholding Notification
2023-01-10 Dutch
6-K Filing
Foreign Filer Report
2023-01-10 English
6-K Filing
Foreign Filer Report
2023-01-05 English
6-K Filing
Foreign Filer Report
2023-01-05 English